597 related articles for article (PubMed ID: 11812936)
41. Prognostic significance of stromal microinvasion in the intestinal type of ovarian mucinous adenocarcinoma.
Kong KY; Park JY; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Nam JH
Ann Surg Oncol; 2011 Nov; 18(12):3462-8. PubMed ID: 21556953
[TBL] [Abstract][Full Text] [Related]
42. Pathologic findings in eight cases of ovarian serous borderline tumors, three with foci of serous carcinoma, that preceded death or morbidity from invasive carcinoma.
Lee KR; Castrillon DH; Nucci MR
Int J Gynecol Pathol; 2001 Oct; 20(4):329-34. PubMed ID: 11603215
[TBL] [Abstract][Full Text] [Related]
43. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
44. Genetic analysis for mucinous ovarian carcinoma with infiltrative and expansile invasion and mucinous borderline tumor: a retrospective analysis.
Hada T; Miyamoto M; Ohtsuka Y; Suminokura J; Ito T; Kishimoto N; Nishitani S; Takada M; Imauji A; Tanabe R; Takano M
Diagn Pathol; 2023 Apr; 18(1):49. PubMed ID: 37081552
[TBL] [Abstract][Full Text] [Related]
45. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
[TBL] [Abstract][Full Text] [Related]
46. Clinicopathologic analysis of early-stage sporadic ovarian carcinoma.
Leitao MM; Boyd J; Hummer A; Olvera N; Arroyo CD; Venkatraman E; Baergen RN; Dizon DS; Barakat RR; Soslow RA
Am J Surg Pathol; 2004 Feb; 28(2):147-59. PubMed ID: 15043303
[TBL] [Abstract][Full Text] [Related]
47. Mucinous ovarian tumors of Mullerian-type: an analysis of 17 cases including borderline tumors and intraepithelial, microinvasive, and invasive carcinomas.
Dubé V; Roy M; Plante M; Renaud MC; Têtu B
Int J Gynecol Pathol; 2005 Apr; 24(2):138-46. PubMed ID: 15782070
[TBL] [Abstract][Full Text] [Related]
48. Mucinous borderline ovarian tumors with and without Intraepithelial Carcinoma: Differences in clinicopathologic features and fertility results.
Chen RF; Tao X; Wu BB; Li J; Wang JY; Gu WY; Lu X
J Obstet Gynaecol Res; 2020 Apr; 46(4):646-653. PubMed ID: 32045956
[TBL] [Abstract][Full Text] [Related]
49. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
50. Pathologic examination accurately predicts prognosis in mucinous cystic neoplasms of the pancreas.
Wilentz RE; Albores-Saavedra J; Zahurak M; Talamini MA; Yeo CJ; Cameron JL; Hruban RH
Am J Surg Pathol; 1999 Nov; 23(11):1320-7. PubMed ID: 10555000
[TBL] [Abstract][Full Text] [Related]
51. The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases.
Lee KR; Young RH
Am J Surg Pathol; 2003 Mar; 27(3):281-92. PubMed ID: 12604884
[TBL] [Abstract][Full Text] [Related]
52. Long-term follow-up of borderline ovarian tumors clinical outcome and prognostic factors.
Lazarou A; Fotopoulou C; Coumbos A; Sehouli J; Vasiljeva J; Braicu I; Burger H; Kuehn W
Anticancer Res; 2014 Nov; 34(11):6725-30. PubMed ID: 25368281
[TBL] [Abstract][Full Text] [Related]
53. Epithelial ovarian tumors of borderline malignancy.
Chao TM; Yen MS; Chao KC; Ng HT
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Aug; 58(2):97-102. PubMed ID: 8915111
[TBL] [Abstract][Full Text] [Related]
54. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases.
Seidman JD; Kurman RJ
Am J Surg Pathol; 1996 Nov; 20(11):1331-45. PubMed ID: 8898837
[TBL] [Abstract][Full Text] [Related]
55. Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature.
Hada T; Miyamoto M; Ishibashi H; Matsuura H; Sakamoto T; Kakimoto S; Iwahashi H; Tsuda H; Takano M
J Ovarian Res; 2021 Feb; 14(1):33. PubMed ID: 33583413
[TBL] [Abstract][Full Text] [Related]
56. Borderline epithelial tumors of the ovary.
Hart WR
Mod Pathol; 2005 Feb; 18 Suppl 2():S33-50. PubMed ID: 15761465
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features.
Lee H; Park CS; Deftereos G; Morihara J; Stern JE; Hawes SE; Swisher E; Kiviat NB; Feng Q
World J Surg Oncol; 2012 Aug; 10():174. PubMed ID: 22925189
[TBL] [Abstract][Full Text] [Related]
58. [Diagnostic problems of ovarian mucinous borderline tumors].
Vereczkey I; Tóth E; Orosz Z
Magy Onkol; 2009 Jun; 53(2):127-33. PubMed ID: 19581178
[TBL] [Abstract][Full Text] [Related]
59. Mucinous carcinoma of the ovary. Pathologic prognostic factors.
Watkin W; Silva EG; Gershenson DM
Cancer; 1992 Jan; 69(1):208-12. PubMed ID: 1309304
[TBL] [Abstract][Full Text] [Related]
60. Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases.
Vang R; Hannibal CG; Junge J; Frederiksen K; Kjaer SK; Kurman RJ
Am J Surg Pathol; 2017 Jun; 41(6):725-737. PubMed ID: 28248817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]